Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients
- Conditions
- Kidney TransplantLiver Transplant
- Interventions
- Device: MoveMend Health
- Registration Number
- NCT06222554
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The objective of this study is to evaluate the feasibility of the MoveMend Health software program as an integrated supplement to traditional acute care/in-hospital occupational therapy for patients following liver and kidney transplants, as determined by recruitment rates, program completion, intervention adherence, safety incidence, and patient feedback on device/program performance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- English speaking (software program is currently only available in English)
- Status post kidney or liver transplant this admission
- Physician orders for occupational therapy evaluation and treatment
- Orientation Log > 25
- Negative for delirium per the Confusion Assessment Method
- Orthopedic or surgical precautions that limits shoulder range of motion beyond 90 degrees
- Upper extremity hemiplegia with inability to lift upper extremity against gravity
- Accommodation code of Intensive Care Unit
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Patients Hospitalized following Kidney or Liver Transplant MoveMend Health Patients in the study will be introduced to the exercise software program and provided with a demonstration. Measurements will be taken at baseline (post-operation) and at the final study visit. Participants will remain in the study until the end of their hospital stay, typically no longer than 6 months post-operation.
- Primary Outcome Measures
Name Time Method Number of Adverse Events Up to Month 6 Post-Operation Measured using data from participant's electronic medical record.
Percentage of Participants who Adhere to Intervention Up to Month 6 Post-Operation Measured by session duration and frequency, as recorded by the device. Participants will be classified as "adhering" or "not adhering."
Recruitment Rate Up to Month 6 Post-Operation Calculated by dividing the number of participants enrolled by the total number of patients contacted or screened.
Percentage of Participants who Complete Exercise Program Up to Month 6 Post-Operation Percentage of enrolled participants who complete the interventional program.
- Secondary Outcome Measures
Name Time Method Change in Activity Measure for Post-Acute Care (AMPAC) Score Baseline, End of Hospital Stay (typically no more than 6 months post-operation) 12-item assessment of basic mobility of inpatients. Each item is rated on a Likert scale from 1-4. The raw score is the sum of responses, which is converted to a T-score. The total score is a T-score ranging from 0 to 100; higher scores indicate greater mobility.
Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L) Questionnaire Index Score Baseline, End of Hospital Stay (typically no more than 6 months post-operation) The EQ-5D-5L is a self-reported health status questionnaire that consists of six questions used to calculate a health utility score for use in health economic analysis. There are two components to the EQ-5D-5L: a five-item health state profile that assesses mobility, self-care, usual activities, pain/discomfort, and anxiety/depression used to obtain an Index Utility Score, as well as a visual analogue scale (VAS) that measures health state. Overall scores range from 0 to 1, with low scores representing a higher level of dysfunction.
Upper Extremity Range of Motion (ROM) Change Baseline, End of Hospital Stay (typically no more than 6 months post-operation) Measured as the change in degrees of ROM at the shoulder and elbow as measured by a goniometer from baseline to discharge.
Change in Grip Strength Baseline, End of Hospital Stay (typically no more than 6 months post-operation) Measured as the percentage change in grip strength between the baseline assessment and the final assessment at discharge.
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States